SCHEMBL352099

SCHEMBL352099

Cc1sc(-c2cccs2)nc1C(N)=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.55
GAA P10253 2/20 0.53
ALDH1A1 P00352 4/20 0.52
ERCC1 P07992 1/20 0.47
FEN1 P39748 1/20 0.47
ERCC4 Q92889 1/20 0.47
RAB9A P51151 4/20 0.45
IKBKB O14920 1/20 0.44
NPC1 O15118 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
TBK1 Q9UHD2 1/20 0.41
EPHX2 P34913 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 1/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6496780 0.86 KDM4E (0.64) KDM4EGAAALDH1A1ERCC1FEN1
SCHEMBL13174890 0.78 FBP1 (0.53) KDM4EGAAALDH1A1ERCC1FEN1
SCHEMBL9629249 0.76 KDM4E (0.54) KDM4EGAAALDH1A1RAB9ANPC1
SCHEMBL10091957 0.75 KDM4E (0.61) KDM4EGAAALDH1A1RAB9ANPC1
SCHEMBL10953772 0.75 TBK1 (0.59) KDM4EALDH1A1KMT2AMEN1TBK1
SCHEMBL12469453 0.73 HTR2B (0.58) ALDH1A1RAB9AIKBKBSMN1; SMN2
SCHEMBL11624332 0.72 ALDH1A1 (0.48) KDM4EALDH1A1ERCC1FEN1ERCC4
SCHEMBL7439562 0.72 TOP2A (0.47) KDM4EGAAALDH1A1ERCC1FEN1
SCHEMBL290222 0.71 KDM4E (0.64) KDM4EGAAALDH1A1RAB9AIKBKB
SCHEMBL288141 0.71 KDM4E (0.78) KDM4EGAAALDH1A1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022077549-A1 COMPOSITION AND METHOD FOR TRANSDIFFERENTIATING NON-NEURONAL CELLS INTO NEURONS 中国科学院动物研究所 2022-04-21 WO claimed
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA KDM4E 1862/4885GAA 602/4885ALDH1A1 2806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.